Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025

Rhea-AI Summary

Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled its second quarter fiscal year 2025 financial results release for August 14, 2025 after market close.

The company will host a conference call at 5:00 p.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Participants can join via phone using access code 13754867 or watch the live webcast on the company's investor relations website. A two-week replay will be available for those unable to attend.

News Market Reaction – VERO

-2.79%

-2.79% Session move

In the trading session that priced this news, VERO declined 2.79%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2025 financial results will be released after the market closes on Thursday, August 14, 2025.

Management will host a conference call at 5:00 p.m. Eastern Time on August 14, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13754867. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13754867. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.

Investor Relations Contact:

ICR Healthcare on behalf of Venus Concept

Mike Piccinino, CFA

VenusConceptIR@ICRHealthcare.com

FAQ

When will Venus Concept (VERO) release Q2 2025 earnings?

Venus Concept will release Q2 2025 earnings on Thursday, August 14, 2025 after the market closes.

How can I listen to Venus Concept's Q2 2025 earnings call?

You can dial 877-407-2991 (201-389-0925 for international) with access code 13754867, or watch the live webcast at ir.venusconcept.com on August 14, 2025 at 5:00 p.m. ET.

What time is Venus Concept's Q2 2025 earnings call?

The earnings conference call is scheduled for 5:00 p.m. Eastern Time on August 14, 2025.

How can I access the replay of Venus Concept's Q2 2025 earnings call?

A replay will be available for two weeks by calling 877-660-6853 (201-612-7415 for international) with access code 13754867, or via webcast archive at ir.venusconcept.com.